Displaying 1241 - 1260 of 1352
Announced Actions for December 27, 2001
Announced Actions for December 21, 2001
Announced Actions for December 7, 2001
Announced Actions for November 20, 2001
Competition and Intellectual Property Policy: The Way Ahead
Muris Announces Plans for Intellectual Property Hearings
Announced Actions for November 13, 2001
FTC Staff Comments on FDAs Plans to Collect Information on Direct-To-Consumer Prescription Drug Advertising
Application for approval of a non-affiliated ISP and alternative cable broadband ISP service agreement:
Announced Actions for October 4, 2001
Web Site Targeting Girls Settles FTC Privacy Charges
Announced Actions for September 28, 2001
FTC Charges Warner Music and Universal Music
Prepared Statement of the Federal Trade Commission On Competition in the Pharmaceutical Marketplace
FTC Testifies on Competition in the U.S. Pharmaceutical Industry
Siemens AG and Vodafone Group Plc, In the Matter of
Siemens settled charges relating to its proposed $9 billion acquisition of Atecs Mannesmann AG, a subsidiary of Vodafone. The consent order requires, among other things, the divestiture of Vodafone's Mannesmann Dematic Postal Automation business to Northrop Grumman Corporation. Siemens and Vodafone, through its Dematic subsidiary, are the two leading suppliers of postal automation systems in the world.
Hoechst Marion Roussel, Inc.; Carderm Capital L.P.; and Andrx Corporation
A consent order settled allegations in an administrative complaint that charged that Hoechst agreed to pay Andrx Corporation millions of dollars not to market and distribute a generic version of Hoechst’s branded Cardizem CD, a once-a-day diltiazem drug product used in the treatment of hypertension and angina. The consent order prohibits the companies from entering into agreements designed to restrict the entry of generic competitors in an attempt to monopolize relevant markets .
Displaying 1241 - 1260 of 1352